Pritesh Shah - Sep 2, 2021 Form 4 Insider Report for NovoCure Ltd (NVCR)

Signature
By: /s/ Steven Robbins, Attorney in fact for Pritesh Shah
Stock symbol
NVCR
Transactions as of
Sep 2, 2021
Transactions value $
-$91,041
Form type
4
Date filed
9/7/2021, 04:32 PM
Previous filing
Aug 6, 2021
Next filing
Mar 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Sale -$21.6K -156 -0.21% $138.23 74K Sep 2, 2021 Direct F1
transaction NVCR Ordinary Shares Sale -$44.4K -321 -0.43% $138.27 73.7K Sep 3, 2021 Direct F2
transaction NVCR Ordinary Shares Sale -$20.9K -150 -0.2% $139.24 73.5K Sep 3, 2021 Direct F3
transaction NVCR Ordinary Shares Sale -$4.21K -30 -0.04% $140.18 73.5K Sep 3, 2021 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2 On September 3, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 321 shares in multiple trades at prices ranging from $137.75 to $138.56. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
F3 On September 3, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 150 shares in multiple trades at prices ranging from $138.81 to $139.78. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
F4 Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah.